Praktisches Vorgehen bei Erstdiagnose einer Leberzirrhose

Abstract

Liver cirrhosis is a major healthcare problem and is associated with an increased mortality due to the development of complications. Therefore, after diagnosis of liver cirrhosis, it is highly clinically relevant to evaluate the reason for liver cirrhosis and to assess the presence of complications in order to prevent progression of liver cirrhosis.

Die Leberzirrhose ist ein häufiges und weltweites Gesundheitsproblem und geht mit einer hohen Mortalität einher. Dies ist vor allem durch das Auftreten von Komplikationen bedingt. Daher ist es bei Erstdiagnose relevant, die Ursache der Leberzirrhose sowie bereits bestehende Komplikationen strukturiert abzuklären, um so ein Fortschreiten der Lebererkrankung und das Auftreten weiterer Komplikationen zu verhindern.

Schlüsselwörter

Leberzirrhose - portale Hypertension - Diagnostik - Aszites - Ösophagusvarizen - Hepatozelluläres Karzinom

Key words

liver cirrhosis - portal hypertension - diagnosis - ascites - esophageal varices - hepatocellular cancer

• Literatur

• 1 Karkmann K, Piecha F, Rünzi AC. et al. Management of compensated liver irrhosis 2018 – Evidence based prophylactic measures. Z Gastroenterol 2018; 56 (01) 55-69
• 2 Blachier M, Leleu H, Peck-Radosavljevic M. et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013; 58: 593-608
• 3 Friedrich-Rust M, Vermehren J. Non-invasive methods for the evaluation of liver fibrosis in clinical practice. Z Gastroenterol 2013; 51: 43-54
• 4 Tannapfel A, Dienes HP, Lohse AW. The indications for liver biopsy. Dtsch Arztebl Int 2012; 109: 477-483
• 5 Marcellin P, Gane E, Buti M. et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study. Lancet 2013; 381: 468-475
• 6 Moreau R, Jalan R, Gines P. et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-1437
• 7 Loulergue P, Pol S, Mallet V. et al. Why actively promote vaccination in patients with cirrhosis?. J Clin Virol 2009; 46: 206-209
• 8 Sturm L, Rössle M, Schultheiß M. Komplikationen der Leberzirrhose – medikamentöse versus interventionelle Therapie. Dtsch Med Wochenschr 2019; 144: 1259-1266
• 9 De Franchis R, Abraldes JG, Bajaj J. et al. Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63 (03) 743-752
• 10 Götz M, Anders M, Biecker E. et al. S2k Guideline Gastrointestinal Bleeding – Guideline of the German Society of Gastroenterology DGVS. Z Gastroenterol 2017; 55 (09) 883-936
• 11 De Gottardi A, Thevenot T, Spahr L. et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol 2009; 7: 906-909
• 12 Gerbes AL, Labenz J, Appenrodt B. et al. Updated S2k-Guideline “Complications of liver cirrhosis”. German Society of Gastroenterology (DGVS). Z Gastroenterol 2019; 57 (05) e168
• 13 Bettinger D, Schultheiss M, Boettler T. et al. Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS). Aliment Pharmacol Ther 2016; 44 (10) 1051-1061
• 14 Caraceni P, Riggio O, Angeli P. et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet 2018; 391: 2417-2429
• 15 EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236
• 16 Bansal RK, Kumar M, Ranjan P. et al. Prospective study of profile of hepatic osteodystrophy in patients with non-choleastatic liver cirrhosis and impact of bisphosphonate supplementation. United European Gastroenterol J 2016; 4 (01) 77-83
• 17 Alcalde Vargas A, Pascasio Acevedo JM, Gutierrez Domingo I. et al. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation. Transplant Proc 2012; 44: 1496-1498
• 18 Collier JD, Ninkovic M, Compston JE. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 2002; 50 (Suppl. 01) i1-i9
• 19 Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol 2014; 20 (25) 8061-8071
• 20 Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol 2012; 27: 430-441